Dear Doctor - Participate in the Survey on epilepsy " A new survey has found that nearly one in three people with epilepsy have experienced at least one seizure in the past year. The findings, from the Epilepsy Foundation's 2020 National Survey of Epilepsy Attitudes and Experiences, also reveal that half of all respondents worry about having a seizure in public."These survey results underscore the urgent need for improved access to care and treatments for people living with epilepsy," said Philip Gattone, CEO of the Epilepsy Foundation. "It is unacceptable that so many people with this condition are still facing challenges in getting the help they need."The survey, which was conducted online between February and March 2020, received more than 4,500 responses from people with epilepsy and their caregivers. Among other things, it found that:- 24% of respondents said they had not seen a doctor or other healthcare provider in the past year specifically for their epilepsy;- 36% said they have not been able to get all of the medication they need; and - 54% reported experiencing at least one seizure in the past year. Participate in Surveys "
1.
Video: Liver transplant for patients with advanced colorectal cancer
2.
La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.
3.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
4.
AI is useful in low-resource areas for triaging breast masses.
5.
Does pollution cause cancer?
1.
Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review
2.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
3.
Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense
4.
Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment
5.
Beyond the Cure: The Emerging Role of Tissue-Agnostic Therapies in Palliative Oncology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
4.
Navigating the Complexities of Ph Negative ALL - Part VII
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation